ArticleChronic Lymphocytic Leukemia Updates From ASH 2021 Author:Jennifer Brown, MD, PhDPublish date: January 6, 2022CLL highlights from ASH 2021 focus on frontline venetoclax regimens, zanubrutinib in high-risk CLL, promisi...Read More
